Search Within

Paolo Codega

Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
  3. Research Letter (1)
Groups
  1. GSK Faculty (9)
  2. Human Oncology and Pathogenesis Program (9)
  3. Sloan Kettering Institute Postdocs (9)
  4. Tow Center for Developmental Oncology (TCDO) (9)
  5. Department of Pathology and Laboratory Medicine (5)
  6. MSK Grad Students (5)

More Groups

People
  1. Ingo Mellinghoff (9)
  2. Carl Campos (8)
  3. Marc Rosenblum (4)
  4. Wan-Ying Hsieh (4)
  5. Barbara Oldrini (3)
  6. Barry Taylor (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2017 (4)
  6. 2016 (1)
Publications
  1. Molecular Biology of the Cell (2)
  2. ACS Medicinal Chemistry Letters (1)
  3. Annals of Neurology (1)
  4. Blood (1)
  5. Cancer Discovery (1)
  6. Nature Communications (1)

More Publications

Publishers
  1. The American Society for Cell Biology (2)
  2. American Association for Cancer Research (1)
  3. American Chemical Society (1)
  4. American Society of Hematology (1)
  5. Elsevier Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modeling reversible tumorigenesis in cerebral organoids
    Meeting Abstract

    Graham, M.; Codega, P.; Campos, C.; Nandakumar, S.; Rosenblum, M.; Antonescu, C.; Grogan, M.; Benhamida, J.; Bale, T.; von Deimling, A.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Inducible transgenic cerebral organoids model oncogene dependence in pediatric tumorigenesis
    Meeting Abstract

    Graham, M. S.; Codega, P.; Campos, C.; Rosenblum, M. K.; Antonescu, C. R.; Nandakumar, S.; Benhamida, J. K.; Bale, T. A.; von Deimling, A.; Socci, N. D.; more...
    Annals of Neurology (2022)

    Fulltext@MSK | Save
  • Vorasidenib (AG-881): A first-in-class, brain-penetrant dual inhibitor of mutant IDH1 and 2 for treatment of glioma
    Research Letter

    Konteatis, Z.; Artin, E.; Nicolay, B.; Straley, K.; Padyana, A. K.; Jin, L.; Chen, Y.; Narayaraswamy, R.; Tong, S.; Wang, F.; more...
    ACS Medicinal Chemistry Letters (2020)

    Fulltext@MSK | Save
  • Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
    Journal Article

    Grommes, C.; Tang, S. S.; Wolfe, J.; Kaley, T. J.; Daras, M.; Pentsova, E. I.; Piotrowski, A. F.; Stone, J.; Lin, A.; Nolan, C. P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Identification of RAN binding protein 6 (RanBP6) as an EGFR feedback regulator and a tumor suppressor in glioblastoma
    Meeting Abstract

    Hsieh, W.; Oldrini, B.; Erdjument-Bromage, H.; Codega, P.; Carro, M. S.; Campos, C.; Taylor, B. S.; Tempst, P.; Squatrito, M.; Mellinghoff, I. K.
    Molecular Biology of the Cell (2017)

    Fulltext@MSK | Save
  • EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
    Journal Article

    Oldrini, B.; Hsieh, W. Y.; Erdjument-Bromage, H.; Codega, P.; Carro, M. S.; Curiel-García, A.; Campos, C.; Pourmaleki, M.; Grommes, C.; Vivanco, I.; more...
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Dissecting glioma invasiveness in a 3D-organotypic model
    Journal Article

    Codega, P.; Mellinghoff, I. K.
    Trends in Molecular Medicine (2017)

    Fulltext@MSK | Save
  • Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma
    Journal Article

    Grommes, C.; Pastore, A.; Palaskas, N.; Tang, S. S.; Campos, C.; Schartz, D.; Codega, P.; Nichol, D.; Clark, O.; Hsieh, W. Y.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Identification of RAN binding protein 6 as EGFR feedback regulator and candidate tumor suppressor
    Meeting Abstract

    Hsieh, W.; Oldrini, B.; Erdjument-Bromage, H.; Codega, P.; Vivanco, I.; Rohle, D.; Campos, C.; Bielski, C. M.; Taylor, B. S.; Tempst, P.; more...
    Molecular Biology of the Cell (2016)

    Fulltext@MSK | Save